ClinicalTrials.govpublic full text
A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
parkinson's disease, levodopa, end of dose wearing off, off time, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842026
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.